REDEMPLO® (plozasiran) is an injectable prescription medicine used together with a low-fat diet to reduce triglycerides (fat in the blood) in adults with a condition that keeps the body from breaking down fats called familial chylomicronemia syndrome (FCS).
I was hired as copy Creative Lead to manage the launch of Redemplo, a drug that significantly lowers triglyceride levels in people diagnosed with Familial Chylomicronemia Syndrome. Elements included a print campaign for patients, a print campaign for HCPs, two websites (one patient, one HCP), a Doctor Discussion Guide, and banner ads to drive to the websites.
Agency: Havas Lynx New York
Role: Associate Creative Director/Copywriter
Art Director: Deniz Eyuboglu